Jaguar animal health to host dinner & tableside discussion for u.s. veterinary oncologists about chemotherapy-induced diarrhea (cid) in dogs on april 12th, the final day of the veterinary cancer society (vcs) mid-year conference in puerto vallarta, mexico

Canalevia™-ca1, which received conditional approval from the fda on december 21, 2021, is the first and only treatment for cid in dogs to receive any type of approval from the fda veterinary oncologists can click here to register for the dinner and tableside discussion san francisco, ca / accesswire / april 6, 2022 / jaguar health, inc. (nasdaq:jagx), under its jaguar animal health tradename for the veterinary market, today announced that the company is hosting a dinner and tableside discussion for u.s. veterinary oncologists in puerto vallarta, mexico from 5:30 pm - 10:00 pm on tuesday, april 12, 2022, the final day of the veterinary cancer society (vcs) mid-year conference. this exclusive dinner experience will feature a private chef, entertainment, and a tableside discussion on treatment therapies for chemotherapy-induced diarrhea (cid) in dogs.
JAGX Ratings Summary
JAGX Quant Ranking